title: Inhibition of a novel specific neuroglial integrin signaling pathway increases STAT3-mediated CNTF expression.
abstract: BACKGROUND
  Ciliary neurotrophic factor (CNTF) expression is repressed in astrocytes by neuronal contact in the CNS and is rapidly induced by injury. Here, we defined an inhibitory integrin signaling pathway.
  
  
  RESULTS
  The integrin substrates laminin, fibronectin and vitronectin, but not collagen, thrombospondin or fibrinogen, reduced CNTF expression in C6 astroglioma cells. Antibodies against αv and β5, but not α6 or β1, integrin induced CNTF. Together, the ligand and antibody specificity suggests that CNTF is repressed by αvβ5 integrin. Antibodies against Thy1, an abundant neuronal surface protein whose function is unclear, induced CNTF in neuron-astrocyte co-cultures indicating that it is a neuroglial CNTF repressor. Inhibition of the integrin signaling molecule Focal Adhesion Kinase (FAK) or the downstream c-Jun N-terminal kinase (JNK), but not extracellular regulated kinase (ERK) or p38 MAPK, greatly induced CNTF mRNA and protein expression within 4 hours. This selective inhibitory pathway phosphorylated STAT3 on its inhibitory ser-727 residue interfering with activity of the pro-transcription Tyr-705 residue. STAT3 can activate CNTF transcription because it bound to its promoter and FAK antagonist-induced CNTF was reduced by blocking STAT3. Microinjection of FAK inhibitor directly into the brain or spinal cord in adult mice rapidly induced CNTF mRNA and protein expression. Importantly, systemic treatment with FAK inhibitors over 3 days induced CNTF in the subventricular zone and increased neurogenesis.
  
  
  CONCLUSIONS
  Neuron-astroglia contact mediated by integrins serves as a sensor to enable rapid neurotrophic responses and provides a new pharmacological avenue to exploit the neuroprotective properties of endogenous CNTF.
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Keasey
authors.forename: Seong Su
authors.initials: SS
authors.lastname: Kang
authors.forename: Chiharu
authors.initials: C
authors.lastname: Lovins
authors.forename: Theo
authors.initials: T
authors.lastname: Hagg
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D045744:Cell Line, Tumor; D020934:Ciliary Neurotrophic Factor / Q000235:genetics / Q000378:metabolism*; D018920:Coculture Techniques; D051416:Focal Adhesion Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D008810:Mice, Inbred C57BL; D055495:Neurogenesis; D009457:Neuroglia / Q000187:drug effects / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D010766:Phosphorylation; D015363:Quinolones / Q000494:pharmacology; D051381:Rats; D019030:Receptors, Vitronectin / Q000378:metabolism*; D050796:STAT3 Transcription Factor / Q000378:metabolism*; D012694:Serine / Q000378:metabolism; D015398:Signal Transduction; D013450:Sulfones / Q000494:pharmacology; D018800:Thy-1 Antigens / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism
chemical_list: C521108:6-(4-(3-(methylsulfonyl)benzylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)-3,4-dihydroquinolin-2(1H)-one; D020934:Ciliary Neurotrophic Factor; D015363:Quinolones; D019030:Receptors, Vitronectin; D050796:STAT3 Transcription Factor; D013450:Sulfones; D018800:Thy-1 Antigens; C064660:integrin alphaVbeta5; D014443:Tyrosine; D012694:Serine; D051416:Focal Adhesion Protein-Tyrosine Kinases